Biocon

Aug 31, 2015 at 20:42 | Source: PTI
"The company is planning to set up a new manufacturing facility at Mangalore SEZ and is in the process of acquiring 40 acres of land and obtaining necessary approvals," Syngene International said in a statement on BSE. The estimated expenditure for setting up the facility is USD 100 million, it added.
Aug 24, 2015 at 15:29 | Source: CNBC-TV18
Pritesh Mehta of IIFL recommends selling UPL August Futures, Biocon and Godrej Industries.
Aug 24, 2015 at 14:20 | Source: CNBC-TV18
Watch the interview of Pritesh Mehta of IIFL with Reema Tendulkar & Mangalam Maloo on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.
Aug 20, 2015 at 17:31 | Source: CNBC-TV18
Kiran Mazumdar Shaw, Chairman and MD, Biocon believes Indias innovation led growth story is what investors are buying into but foreign investors need predictability and clarity in policies and regulations.
Aug 15, 2015 at 16:09 | Source: CNBC-TV18
Market, media and India Inc experts decode Prime Minister Narendra Modi's speech on the occasion of India's 69th Independence Day.
Aug 11, 2015 at 17:05 | Source: Moneycontrol.com
Shares of Syngene International closed the first session above Rs 300-mark on Tuesday, after hitting an intraday high of Rs 318.50 (up 27.4 percent) and low of Rs 295 apiece compared to issue price.
Aug 11, 2015 at 13:07 | Source: CNBC-TV18
Biocon CMD Kiran Mazumdar Shaw is confident that given the kind of business Syngene commands today, it will evince a lot of interest
Aug 11, 2015 at 12:16 | Source: CNBC-TV18
Mahantesh Sabarad of SBI Capital Securities likes PTC India Financial Services from the NBFC space and feels that Dr Reddy's Laboratories and Biocon can do substantially well from the pharma space.
Aug 11, 2015 at 12:15 | Source: CNBC-TV18
Mahantesh Sabarad of SBICAP Securities is bullish on financial NBFC space, select pharma companies and IT stocks. He likes PTC India, Dr Reddy's Lab, Biocon, Infosys and Firstsource, among others.
Aug 11, 2015 at 10:21 | Source: Moneycontrol.com
Syngene offers integrated drug discovery and development services with capabilities in medicinal chemistry, biology and toxicology.
Messages on Biocon »

subs74

Silver Member

4 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th 2014

ScorpioKing
-KD

Gold Member

553 Followers

Biocon  

Any specific relation would have to seen in main budget - my point was that if overall market tanks badly - Biocon wont be exception. Not necessarily related to biocon. Long due correction in market.

3.52 PM Jul 8th 2014

subs74

Silver Member

4 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th 2014

namo8081

New Member

3 Followers

Biocon  

kal biocon 520 ke niche milega

2.56 PM Jul 8th 2014

dr.sachin

New Member

3 Followers

Biocon  

biocon has nothing to do with railway budget still creeping down

1.54 PM Jul 8th 2014

hrasvs

New Member

1 Followers

Biocon  

may biocon taste 650 lvl by end aug14.

12.31 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

9246 Followers

Biocon  

Biocon Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.08 AM Jul 8th 2014

sanecounsel

Platinum Member

117 Followers

Biocon  

the outcome of the Delhi High Court case brought by Roche against Biocon and Mylan in February gains significance. Roche has alleged that Biocon/Mylan has misrepresented its drugs as a biosimilar of its bestselling breast cancer drug, Trastuzumab (Herceptin), without having undergone the required

10.04 AM Jul 8th 2014

niceworld

Platinum Member

5808 Followers

Granules India  

`t care because I do believe this and the results have been terrific till now in my life.There are many examples.Biocon was one of such examples... contd.

10.21 PM Jul 7th 2014

neo_ice

New Member

0 Follower

Biocon  

heavy buying seen at day`s end with high volumes .... brakout pattern from all time high also suggests eminent rise - My target for Biocon is Rs 580 for the short term

3.43 PM Jul 7th 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.